Skip to main content
Premium Trial:

Request an Annual Quote

Enzo, Siemens Resolve IP Infringement Case

NEW YORK (GenomeWeb) – Enzo Life Sciences today announced it and Siemens Healthcare Diagnostics have agreed to settle a dispute alleging patent infringement. 

As part of the deal, Siemens will pay Enzo $9.5 million upfront. Enzo is also eligible to receive up to $5 million in licensing fees depending on the sale of additional Siemens products during a five-year period. In return, Enzo discharges Siemens from any claim of infringement of US Patent No. 7,064,197. 

The patent is at the center of a dozen lawsuits that Enzo has filed against competitors alleging infringement of the '197 patent, as well as other patents. The settlement is the second reached by Enzo involving the '197 patent. Earlier this month, Luminex agreed to pay Enzo $7.1 million to settle their dispute.

Enzo Life Sciences is a wholly owned subsidiary of Enzo Biochem.

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.